Abstract:Background To reduce cancer mortality and improve cancer outcomes, it is critical to understand the various cancer risk factors (RFs) across different domains (e.g., genetic, environmental, and behavioral risk factors) and levels (e.g., individual, interpersonal, and community levels). However, prior research on RFs of cancer outcomes, has primarily focused on individual level RFs due to the lack of integrated datasets that contain multi-level, multi-domain RFs. Further, the lack of a consensus and proper guidance on systematically identify RFs also increase the difficulty of RF selection from heterogenous data sources in a multi-level integrative data analysis (mIDA) study. More importantly, as mIDA studies require integrating heterogenous data sources, the data integration processes in the limited number of existing mIDA studies are inconsistently performed and poorly documented, and thus threatening transparency and reproducibility. Methods Informed by the National Institute on Minority Health and Health Disparities (NIMHD) research framework, we (1) reviewed existing reporting guidelines from the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) network and (2) developed a theory-driven reporting guideline to guide the RF variable selection, data source selection, and data integration process. Then, we developed an ontology to standardize the documentation of the RF selection and data integration process in mIDA studies. Results We summarized the review results and created a reporting guideline—ATTEST—for reporting the variable selection and data source selection and integration process. We provided an ATTEST check list to help researchers to annotate and clearly document each step of their mIDA studies to ensure the transparency and reproducibility. We used the ATTEST to report two mIDA case studies and further transformed annotation results into sematic triples, so that the relationships among variables, data sources and integration processes are explicitly standardized and modeled using the classes and properties from OD-ATTEST. Conclusion Our ontology-based reporting guideline solves some key challenges in current mIDA studies for cancer outcomes research, through providing (1) a theory-driven guidance for multi-level and multi-domain RF variable and data source selection; and (2) a standardized documentation of the data selection and integration processes powered by an ontology, thus a way to enable sharing of mIDA study reports among researchers. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This study was supported in part by the National Institute of Health (NIH) awards UL1TR001427 and R01CA246418 and Patient-Centered Outcomes Research Institute (PCORI) award ME-2018C3-14754. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or PCORI. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Our study doesn't require IRB approval. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes All the data needed are included in the manuscript. * ACS : American Cancer Society BRFSS : Behavioral Risk Factor Surveillance System EQUATOR : Enhancing the QUAlity and Transparency Of health Research FCDS : Florida Cancer Data System mIDA Multi-level Integrative Data Analysis NIH : National Institute of Health NIMHD : Minority Health and Health Disparities OD-ATTEST : Ontology for the Documentation of Variable and Data Source Selection and Integration Process RF : Risk Factor US : United States RUCA : Rural-Urban Commuting Area NCHS : National Center for Health Statistics BFO : Basic Formal Ontology NCBO : National Center for Biomedical Ontology RDF : Resource Description Framework GRIPS : Genetic RIsk Prediction Studies COHERE : Checklist for One Health Epidemiological Reporting of Evidence EHR Electronic Health Records OBI : Ontology for Biomedical Investigations IAO : Information Artifact Ontology NCIt : National Cancer Institute Thesaurus STATO : Statistics Ontology SIO : Semanticscience Integrated Ontology CDM : Common Data Model PCORnet : The national Patient-Centered Clinical Research Network

Standardizing Extracted Data Using Automated Application of Controlled Vocabularies

Clearing the standards landscape: the semantics of terminology and their impact on toxicogenomics

An Ontology-based Approach to Guide and Document Variable and Data Source Selection and Data Integration Process to Support Integrative Data Analysis in Cancer Outcomes Research

Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS

The application of natural language processing for the extraction of mechanistic information in toxicology

Standardizing non-targeted analysis reporting to advance exposure science and environmental epidemiology

Investigating Deep-Learning NLP for Automating the Extraction of Oncology Efficacy Endpoints from Scientific Literature

From vision toward best practices: Evaluating in vitro transcriptomic points of departure for application in risk assessment using a uniform workflow

Data extraction methods for systematic review (semi)automation: Update of a living systematic review

Use cases, best practice and reporting standards for metabolomics in regulatory toxicology

FDA toxicity databases and real-time data entry

Cross study analyses of SEND data: toxicity profile classification

An automated computational data pipeline to rapidly acquire, score, and rank toxicological data for ecological hazard assessment

Voluntary Exploratory Data Submissions to the Us Fda and the Ema: Experience and Impact

Current data processing methods and reporting standards for untargeted analysis of volatile organic compounds using direct mass spectrometry: a systematic review

Automating data extraction in systematic reviews: a systematic review

Granularly, Precisely, and Timely: Leveraging Large Language Models for Safety and Efficacy Extraction in Oncology Clinical Trial Abstracts (SEETrials)

Summarising good practice guidelines for data extraction for systematic reviews and meta-analysis

Towards the development of an omics data analysis framework

medExtractR: A targeted, customizable approach to medication extraction from electronic health records

Data Extraction and Management in Networks of Observational Health Care Databases for Scientific Research: A Comparison of EU-ADR, OMOP, Mini-Sentinel and MATRICE Strategies